Purpose: We evaluated and optimized the detection of cancer by prostat
e biopsies. We developed a stochastic computer simulation model of ult
rasound guided biopsies using mathematically reconstructed radical pro
statectomy specimens. Use of this technique allows rapid evaluation of
a variety of factors for their effect on prostate biopsy results. We
used this model to analyze the effectiveness of sextant biopsies, whic
h have been widely adopted in clinical practice. We also analyzed othe
r biopsy schemes. Materials and Methods: A total of 607 tumor foci fro
m 180 serially sectioned whole mount radical prostatectomy specimens w
as mapped and digitized. The cancers had been clinically diagnosed by
a variety of biopsy strategies. Simulated parasagittal sextant biopsie
s were performed for each case. Forty simulation runs (each consisting
of a set of 6 biopsies) were performed for each prostate, with realis
tic random variations in sextant biopsy localization programmed in eac
h run. Cancer detection by biopsy was considered reliable if 90% of th
e simulation runs for each prostate were positive for cancer. A summar
y algorithm was used to map the tumor foci. Results: Simulation of sex
tant biopsies demonstrated reliably detected cancer in only 107 of 147
patients (73%) in whom total tumor volume was greater than 0.5 cc. Th
ere was little correlation between total length of cancer in biopsy co
res and tumor volume. Change of biopsy angle from 30 to 45 degrees did
not result in significantly increased detection rates. Similarly, pla
cing all biopsies more laterally did not increase overall detection ra
tes. When we mapped tumor foci from the 40 cases in which sextant biop
sies did not reliably detect tumor, we found that the foci were distri
buted in areas not biopsied by the sextant method, that is the transit
ion zone, midline peripheral zone and inferior portion of the anterior
horn of the peripheral zone. A 10-core biopsy scheme incorporating th
ese areas as well as the posterolateral prostate reliably detected can
cer in 141 of 147 patients (96%) with total tumor volumes greater than
0.5 cc. Conclusions: Prostate cancer of significant volume can be pre
sent in areas not sampled by standard sextant biopsies. Biopsies of th
e transition zone, midline peripheral zone and inferior portion of the
anterior horn of the peripheral zone should be considered for re-biop
sy strategy after negative sextant biopsies. Sampling of these additio
nal areas also can be incorporated in an initial biopsy scheme to incr
ease overall initial rates of detection of prostate cancer.